Do people with schizophrenia have a reduced life expectancy?

Yes, People with Schizophrenia Have Significantly Reduced Life Expectancy

People with schizophrenia die 15-21 years earlier than the general population, with mortality rates 1.5-2 times higher than average. This represents one of the most severe health disparities in modern medicine and demands aggressive preventive intervention 1, 2.

The Mortality Gap: Key Numbers

The evidence is unequivocal and alarming:

• Life expectancy is reduced by 17-21 years compared to the general population 1, 2
• Mean age at death is approximately 59-60 years versus 77-81 years in the general population 1, 2
• Standardized mortality ratios range from 1.58 to 2.0, meaning people with schizophrenia are dying at nearly twice the rate of matched controls 1, 2
• 14-19% of patients die within 10-20 years of diagnosis 1, 3

Primary Causes of Premature Death

The mortality pattern reveals preventable causes:

Natural Causes (>80% of deaths)

• Cardiovascular disease is the leading killer (27-28% of all deaths) 1, 2
• Cancer shows higher mortality despite inconsistent incidence data 4
• Respiratory diseases and infections (17%) 1
• Metabolic complications from both illness and treatment 5

Violent Deaths (17-20% of deaths)

• Suicide risk is 15-fold higher than the general population 2
• Accidents and other violent causes contribute significantly 1

Why This Happens: The Deadly Triad

1. Biological and Illness Factors

The disease itself creates vulnerability through genetic predisposition, symptom-related self-neglect, and metabolic dysregulation 5.

2. Treatment-Related Complications

Antipsychotic medications, while life-saving for psychosis, contribute to cardiometabolic risk through weight gain, diabetes, and lipid abnormalities 6, 5. However, use of second-generation antipsychotics actually reduces mortality (HR 0.37) when properly monitored, highlighting that treatment benefits outweigh risks 1.

3. Healthcare System Failures

This is the most modifiable factor. Multiple studies document:

• Diagnostic delays for physical illness 4, 7
• Unclear responsibility between psychiatric and primary care 7
• Suboptimal screening practices despite clear guidelines 5
• Inequitable access to oncological and cardiac treatments 4
• Fragmented care coordination 7

Critical Protective Factors

The most recent evidence identifies what actually saves lives:

• Sustained antipsychotic treatment (HR 0.37 for mortality) 1
• Low hospitalization frequency (HR 0.09) - indicating stable outpatient management 1
• Symptom remission and recovery (HR 0.08-0.21) 3
• Employment at baseline (HR 0.47) 3
• Absence of substance use - substance use increases mortality 2.5-3.6 fold 1, 3

What Must Be Done: Actionable Interventions

Based on the 2025 INTEGRATE guidelines 6 and mortality data, implement this monitoring protocol:

Mandatory Cardiometabolic Screening

• At baseline: BMI, waist circumference, blood pressure, HbA1c, fasting glucose, lipids, ECG 6
• During antipsychotic initiation: Weekly BMI/BP/waist for 6 weeks, fasting glucose at 4 weeks 6
• Ongoing: Repeat full panel at 3 months, then annually 6

Aggressive Risk Factor Management

• Lifestyle interventions for all patients: diet, physical activity, tobacco cessation 6
• Pharmacological treatment for tobacco (varenicline, bupropion, nicotine replacement) 6
• Alcohol use: Naltrexone for harmful use 6
• Immediate treatment of diabetes, hypertension, and dyslipidemia - don't defer to "someone else" 6, 7

System-Level Solutions

• Clarify responsibility - psychiatric providers must own cardiometabolic monitoring 6, 7
• Integrated care plans with defined coordination between psychiatry and primary care 7
• Suicide prevention protocols given 15-fold elevated risk 2

Critical Pitfalls to Avoid

1. Assuming primary care will handle physical health - this leads to care gaps and deaths 7
2. Stopping antipsychotics due to metabolic concerns - untreated psychosis increases mortality more than medication side effects 1
3. Accepting "difficult to engage" as an excuse - this population requires assertive outreach, not passive availability 7
4. Delaying cancer screening or treatment due to psychiatric symptoms 4

Gender Considerations

Men with schizophrenia face greater mortality burden than women, requiring potentially more intensive monitoring 2.

The evidence is clear: this 17-21 year mortality gap is largely preventable through systematic cardiometabolic monitoring, sustained psychiatric treatment, aggressive management of physical comorbidities, and elimination of care fragmentation between psychiatric and medical services 6, 1, 2, 7.